XML 62 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Zimmer Development Agreement (Details) - USD ($)
12 Months Ended
Aug. 02, 2022
Sep. 30, 2022
Sep. 30, 2021
Zimmer Development Agreement (Details) [Line Items]      
Initial fee payment   $ 2,000,000  
Aggregate number of warrants exercisable (in Shares)   350,000  
Warrants exercise price (in Dollars per share)   $ 3  
Fair value of warrants   $ 100,000  
Risk-free interest rate   2.90%  
Expected volatility percentage   53.50% 55.90%
Expected life   5 years  
Expected dividend yield percentage   0.00% 0.00%
Development agreement   $ 5,400,000  
Initial exclusivity fee   2,000,000  
Under payment   3,500,000  
Product revenue   171,169 $ 178,146
Total advertising expense   270,612 338,837
Development Agreement [Member]      
Zimmer Development Agreement (Details) [Line Items]      
Collaborations revenue recognized   1,948,872 $ 64,812
Scenario Two [Member] | Development Agreement [Member] | Modified Connector by April 30, 2021 [Member]      
Zimmer Development Agreement (Details) [Line Items]      
Milestone payments paid   3,500,000  
Scenario Two [Member] | Development Agreement [Member] | Modified Connector by September 30, 2021 [Member]      
Zimmer Development Agreement (Details) [Line Items]      
Milestone payments paid   2,000,000  
Scenario One [Member] | Development Agreement [Member] | April 30, 2021 [Member]      
Zimmer Development Agreement (Details) [Line Items]      
Future potential milestone payments to Neuroone $ 1,500,000    
Scenario One [Member] | Development Agreement [Member] | On or before June 30, 2021 [Member]      
Zimmer Development Agreement (Details) [Line Items]      
Fair value of warrants   $ 100,000